Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection

Conditions:   Hepatitis C Infection;   HIV Infection Interventions:   Drug: Glecaprevir/Pibrentasvir (G/P);   Drug: Ribavirin (RBV) Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   AbbVie Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials